Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
Objective: DNA damage response (DDR) genes have low mutation rates, which may restrict their clinical applications in predicting the outcomes of immune checkpoint inhibitor (ICI) treatment. Thus, a systemic analysis of multiple DDR genes is needed to identify potential biomarkers of ICI efficacy. Me...
Enregistré dans:
Auteurs principaux: | Zhe Gong, Yue Yang, Jieyun Zhang, Weijian Guo |
---|---|
Format: | article |
Langue: | EN |
Publié: |
China Anti-Cancer Association
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/29cb4935ee744defb0f69f530c0874a9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy
par: Emre Küçükköse, et autres
Publié: (2021) -
Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
par: Chinese Society of Clinical Oncology, Expert Committee on Tumor Vascular-targeted Therapy, et autres
Publié: (2021) -
Mismatch Repair of DNA Replication Errors Contributes to Microevolution in the Pathogenic Fungus <italic toggle="yes">Cryptococcus neoformans</italic>
par: Kylie J. Boyce, et autres
Publié: (2017) -
Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations
par: Yang W, et autres
Publié: (2020) -
uvsZ1 mutation shows epistatic relations with uvsD153 and uvsJ1 mutations without any involvement with checkpoint control in Aspergillus nidulans
par: BAPTISTA,FRANCIELLE, et autres
Publié: (2002)